Tumour necrosis factor-alpha levels as predictor factor on clinical response of anthracycline-based neoadjuvant chemotherapy in locally advance breast cancer patients: experimental research

The prevalence of locally advanced breast cancer is increasing yearly, so biomarkers are needed to assist in its management, one of which is tumour necrosis factor-alpha (TNF-α). OBJECTIVE: Analysing TNF-α levels as a predictor factor on clinical response anthracycline-based neoadjuvant chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Adrian, Kevin, Ghaib, Husnul, Ali, Iskandar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129095/
https://www.ncbi.nlm.nih.gov/pubmed/37113871
http://dx.doi.org/10.1097/MS9.0000000000000424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129095/
https://www.ncbi.nlm.nih.gov/pubmed/37113871
http://dx.doi.org/10.1097/MS9.0000000000000424

Ejemplares similares